THE GLOBAL FUND’S 42ND BOARD MEETING CONFIRMS 2020-2022 ALLOCATIONS, COMMITTEE SELECTION PROCESSES, AND EXPANSION OF WAMBO.ORG
ABSTRACT
The Global Fund held its 42nd Board Meeting on 14-15 November at the Global Health Campus in Geneva. This article gives an overview of the main decisions made by the Global Fund Board at this meeting, including those taken through electronic voting prior to the meeting, and summarizes discussions on two other topics that featured during the Board ‘pre-day’.
Global Fund Board approves updated allocation methodology for 2020-2022
ABSTRACT
The allocation methodology for 2020-2022 will be very similar to the methodologies used for the last two allocation periods. The methodology prioritizes funding for high-burden and low-income countries. In approving the methodology, the Board decided that up to $800 million of the funds available for country allocations will be used to top up components that require “paced reductions” and components that previously received less funding than the formula calls for.
Main decisions at Global Fund’s 41st Board meeting include updated allocations methodology and restricted financial contributions
ABSTRACT
The Global Fund held its 41st Board Meeting on 15-16 May at the Global Health Campus in Geneva. This article summarizes the main decisions made by the Global Fund Board at this meeting, one withdrawn decision point, recent decisions taken through electronic voting prior to the meeting, and a few of the many other topics discussed during the two-day meeting and the ‘Pre-Day’ sessions.
By Adèle Sulcas and David Garmaise A look at decision items planned for the 15–16 May Global Fund Board meeting
ABSTRACT
At its meeting on 15-16 May, the Global Fund Board is expected to approve an allocation methodology for the 2020–2022 allocation period. This article provides a preview of the decisions expected at the Board meeting.
Global Fund Board reviews allocation methodology in advance of decision at May 2019 meeting
ABSTRACT
The Global Fund’s 40th Board meeting dedicated a session to allocation methodology, following Strategy Committee discussions on the allocation methodology for 2020–2022. The Board is expected to approve the methodology at its meeting in May 2019. The committee says that no significant changes are expected compared to the methodology used for the 2017–2019 allocations period, but that some refinements are likely. The committee also discussed catalytic investments.
Work underway to refine the Global Fund’s allocation methodology for 2020–2022
ABSTRACT
There are less than 20 months before letters are expected to go out to inform countries of their allocations for 2020–2022. Work has already begun on refining the methodology and process to be used for the 2020–2022 allocations. The Strategy Committee has agreed on the timelines and process.
LE FONDS MONDIAL DEVRAIT ALIGNER SES INVESTISSEMENTS À EFFET CATALYSEUR AUX OBJECTIFS MONDIAUX POUR L'ÉRADICATION DU PALUDISME
RÉSUMÉ
L’application de la formule de niveau charge de morbidité / de revenu qui est au cœur de la méthode de répartition du Fonds mondial pour 2017-2019 désavantagera certains pays qui sont en bonne voie d’éliminer le paludisme. Rima Shretta et Erika Larson font valoir que les ajustements qualitatifs et les fonds mis de côté pour les investissements à effet catalyseur devraient être utilisés pour faire en sorte que ces pays reçoivent un niveau d'investissement approprié. Les auteurs décrivent la façon dont cela peut être fait.
By Rima Shretta and Erika Larson MORE IS KNOWN ABOUT THE IMPACT OF THE NEW ALLOCATION METHODOLOGY
ABSTRACT
The new allocations methodology will lead to significant increases in funding for some regions and diseases, and significant decreases in others. This article explores the implications.
WILL THE PROCESS TO APPLY QUALITATIVE ADJUSTMENTS TO THE ALLOCATIONS FOR 2017-2019 REALLY BE MORE TRANSPARENT?
ABSTRACT
When The Global Fund Board approved the allocation methodology for 2017-2019, it said that the process for making qualitative adjustments will be more transparent. David Garmaise says he is not optimistic.
You've reached the end of the list.